162 related articles for article (PubMed ID: 11231712)
1. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia.
Klepfish A; Berrebi A; Schattner A
Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712
[No Abstract] [Full Text] [Related]
2. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
Sabbà C; Gallitelli M; Palasciano G
N Engl J Med; 2001 Sep; 345(12):926. PubMed ID: 11565536
[No Abstract] [Full Text] [Related]
3. Tranexamic acid in hereditary hemorrhagic telangiectasia.
Lozano M
N Engl J Med; 2002 Feb; 346(6):457. PubMed ID: 11832543
[No Abstract] [Full Text] [Related]
4. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
Flanagan BA; Collins C; Parra S
Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
[TBL] [Abstract][Full Text] [Related]
5. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
[TBL] [Abstract][Full Text] [Related]
6. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study.
Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J
Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
[TBL] [Abstract][Full Text] [Related]
8. Use of a mucosal atomization device for local application of tranexamic acid in epistaxis.
Heymer J; Schilling T; Räpple D
Am J Emerg Med; 2018 Dec; 36(12):2327. PubMed ID: 29685357
[No Abstract] [Full Text] [Related]
9. Best evidence topic reports. BET 3: Topical intranasal tranexamic acid for spontaneous epistaxis.
Hilton L; Reuben A
Emerg Med J; 2014 May; 31(5):436-7. PubMed ID: 24846097
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid and bevacizumab in hereditary hemorrhagic telangiectasia patients presenting with epistaxis.
Lacout A; Marcy PY; El Hajjam M; Lacombe P
Cutis; 2013 Apr; 91(4):173-4. PubMed ID: 23763075
[No Abstract] [Full Text] [Related]
12. Is topical tranexamic acid a better alternative for selected cases of anterior epistaxis management in the ED?
Hassen GW; Clemons P; Kaplun M; Kalantari H
Am J Emerg Med; 2018 Apr; 36(4):734.e1-734.e2. PubMed ID: 29310981
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis].
Pérez del Molino A; Zarrabeitia R; Fernández A; Botella LM
Med Clin (Barc); 2004 Jun; 123(3):118-9. PubMed ID: 15225479
[No Abstract] [Full Text] [Related]
14. Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis.
Hsu YP; Hsu CW; Bai CH; Cheng SW; Chen C
Otolaryngol Head Neck Surg; 2019 Jan; 160(1):22-35. PubMed ID: 30200816
[TBL] [Abstract][Full Text] [Related]
15. Novel use of tranexamic acid to reduce the need for Nasal Packing in Epistaxis (NoPac) randomised controlled trial: research protocol.
Reuben A; Appelboam A; Barton A; Vickery PJ; Body R; Hilton M; Coppell J; Ewings P
BMJ Open; 2019 Feb; 9(2):e026882. PubMed ID: 30772866
[TBL] [Abstract][Full Text] [Related]
16. Use of Atomized Intranasal Tranexamic Acid as an Adjunctive Therapy in Difficult-to-Treat Epistaxis.
Sarkar D; Martinez J
J Spec Oper Med; 2019; 19(2):23-28. PubMed ID: 31201748
[TBL] [Abstract][Full Text] [Related]
17. BET 1: Intravenous tranexamic acid in the treatment of acute epistaxis.
Fox H; Hunter F
Emerg Med J; 2015 Dec; 32(12):969-70. PubMed ID: 26598634
[TBL] [Abstract][Full Text] [Related]
18. Hereditary hemorrhagic telangiectasia/avastin.
Davidson TM; Olitsky SE; Wei JL
Laryngoscope; 2010 Feb; 120(2):432-5. PubMed ID: 19998344
[TBL] [Abstract][Full Text] [Related]
19. Does Oral or Topical Tranexamic Acid Control Bleeding From Epistaxis?
Bridwell RE; April MD; Long B
Ann Emerg Med; 2019 Aug; 74(2):300-302. PubMed ID: 31060746
[No Abstract] [Full Text] [Related]
20. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.
Gaillard S; Dupuis-Girod S; Boutitie F; Rivière S; Morinière S; Hatron PY; Manfredi G; Kaminsky P; Capitaine AL; Roy P; Gueyffier F; Plauchu H;
J Thromb Haemost; 2014 Sep; 12(9):1494-502. PubMed ID: 25040799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
